Immunotherapy boosts the immune system to fight cancer but may cause skin side effects; early reporting helps manage symptoms ...

Colorectal cancer is projected to impact more than 158,000 Americans in 2026. Learn about an immunotherapy-based treatment ...

Pachon in Motion/Pexels. For decades, the standard of care for bowel cancer has been a grueling, predictable cycle: surgery ...

The ATOMIC Trial shows how adding immunotherapy to chemotherapy may reduce recurrence risk and improve outcomes in stage III ...

A UK-led trial of pembrolizumab given before surgery for high-risk bowel cancer has reported no relapses after nearly three years of follow-up. The NEOPRISM-CRC study treated patients with a specific ...

Bladder cancer survivors and local health leaders are rallying the Cincinnati community for the city’s first Walk to End ...

A new study found zero relapses among patients given a new treatment regime, with far better results than would be expected ...

A new UCLA Health Jonsson Comprehensive Cancer Center study suggests that the way immune cells are organized inside melanoma tumors may help researchers better understand which patients will benefit ...

A new grant from the American Cancer Society (ACS) will fund research into a new strategy for targeting glioblastoma at MUSC ...

An AI model applied to pathology slides accurately predicts immunotherapy response in patients with metastatic non-small cell ...

Patients with a specific type of bowel cancer who were treated with a short course of immunotherapy before surgery instead of ...

Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide, with limited curative options. Tumor vaccines ...